- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04304417
The Role of Group Identity on the Community Integration of People With Severe Mental Disorder
This study analyzes which variables enhance or hinder community integration among people with severe mental disorder. Participants will complete a questionnaire to test our hypotheses:
- Hypothesis 1: group identification predicts less self-dehumanization and self-stigma, and more empowerment, these in turn predict more community integration.
- Hypothesis 2: the relationship between group identification and self-dehumanization and self-stigma is moderated by group value.
- Hypothesis 3: when group identification is low, group identification predicts higher community integration, but this relationship is mediated by diagnosis concealment.
Study Overview
Status
Detailed Description
Community integration, which includes physical integration (e.g. participation in activities, as well as use of goods and services in the community in a self-initiated manner), social integration (e.g. quantity and quality of social relationships) and psychological integration (e.g. perception of belongingness to the community), is a necessary element to achieve personal recovery among people with severe mental disorder (SMD).
Group identification, based on Social Identity Theory, emphasizes an individual's definition of who they are in relation to their group membership. When individuals have a strong tendency to define their self-concept in terms of the group they belong to and uphold the values of their group, they are said to have high identification with the group. Group value, on the other hand, refers to the evaluative judgment of one's social group, which reflects the extent to which individuals feel positively or negatively toward their ingroup, and people who have positive perceptions toward their group are more strongly identified with it.
Self-dehumanization is the process by which people dehumanize themselves. This can happen in two ways: when they perceiving themselves as unintelligent, amoral, irrational, wild, etc.; thus perceived as animal-like, it is called animalistic dehumanization; or when they perceive themselves as lacking emotion, warmth, vitality, etc.; perceived as object-like, which is referred to as mechanistic dehumanization.
Self-stigma occurs when people accept the negative stereotypes about their in-group apply to themselves. This has shown to influence the community integration of people with SMD.
Empowerment is understood as the process by which people, organizations and communities acquire control over their own lives. People with SMD who endorsed higher group value were more likely to be involved in educating the public about mental health and helping others with mental disorder, which are considered a behavioral manifestation of empowerment.
In order to test the hypotheses previously mentioned, the users of the public centers of social care for people with SMD of the State of Madrid (Spain) will be contacted. The inclusion criteria are: to have a diagnosis of SMD and disorder consciousness. The exclusion criteria are: to be underage and legally incapacitated. Participants will complete a pencil-and-paper questionnaire, including the measurement of the variables previously mentioned and some socio-demographical questions, in the centers they attend.
The analytical program SPSS.25 (Statistical Package for the Social Sciences) will be used to conduct the appropriate test of hypothesis (correlation, regression, mediation, moderation).
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
State Of Madrid
-
Madrid, State Of Madrid, Spain
- Grupo 5
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Having a diagnosis of severe mental disorder.
- Having disorder consciousness.
Exclusion Criteria:
- Being underage.
- Being legally incapacitated.
Study Plan
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Cross-Sectional
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Physical integration
Time Frame: 1 day. Measured the day of the study.
|
Self-reported frequency of activities realized outdoors, measured with the subscale 'Leisure and community' from the 'Independent living skills survey'.
Each item is scored from 1 (never) to 5 (always).
|
1 day. Measured the day of the study.
|
Social integration
Time Frame: 1 day. Measured the day of the study.
|
Self-reported frequency of support available, measured with the Medical Outcome Study Social Support Survey (MOS-SSS).
Each item is scored from 1 (never) to 5 (always).
|
1 day. Measured the day of the study.
|
Psychological integration
Time Frame: 1 day. Measured the day of the study.
|
Self-reported feeling of belonging to the general community and to the community of people with mental disorder.
It is measured with the subscale 'Belonging' from the 'Community Integration Measure'.
Each item is scored from 1 (I totally disagree) to 5 (I totally agree).
|
1 day. Measured the day of the study.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Self-dehumanization
Time Frame: 1 day. Measured the day of the study.
|
Haslam's scale of Human Nature and Human Uniqueness to measure wether participants think different adjectives describe them.
Each item is scored from 1 (I am not at all like that) to 7 (I am exactly like that).
|
1 day. Measured the day of the study.
|
Self-stigma
Time Frame: 1 day. Measured the day of the study.
|
Self-reported measure of participants' internalized stigma using the 'Internalized Stigma of Mental Illness Inventory-9'.
Each item range from 1 (I totally disagree) to 4 (I totally agree).
|
1 day. Measured the day of the study.
|
Empowerment
Time Frame: 1 day. Measured the day of the study.
|
Self-reported measure of empowerment using the subscales 'Self-esteem-self-efficacy' and 'Community activism and autonomy' from the empowerment scale developed by Rogers, Chamberlin, Ellison y Crean (1997), and the subscale 'disclosure' developed by King et al. (2007).
Items range from 1 (I totally disagree) to 4 (I totally agree).
|
1 day. Measured the day of the study.
|
Group identity
Time Frame: 1 day. Measured the day of the study.
|
The subscales 'Interconnection of self with the group' and 'Sense of interdependence' from the team identity scale developed by Heere and James (2007).
Items range from 1 (I totally disagree) to 7 (I totally agree).
|
1 day. Measured the day of the study.
|
Group value
Time Frame: 1 day. Measured the day of the study.
|
The subscale 'Private evaluation' from the team identity scale developed by Heere and James (2007).
Items range from 1 (I totally disagree) to 7 (I totally agree).
|
1 day. Measured the day of the study.
|
Collaborators and Investigators
Investigators
- Principal Investigator: Carolina Ugidos, Complutense University of Madrid
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2019/20-020
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Personality Disorders
-
Icahn School of Medicine at Mount SinaiCompletedBorderline Personality Disorders | Avoidant Personality DisordersUnited States
-
University Hospital, Basel, SwitzerlandLeading House for the Latin American Region (Seed Money Grant SMG 1730)WithdrawnBorderline Personality Disorder (BPD)
-
University of Colorado, DenverCompleted
-
Health Service Executive, IrelandCompletedPersonality Disorder, Borderline
-
NHS Greater Glasgow and ClydeUnknownBorderline Personality Disorder (BPD) | Antisocial Personality Disorder (ASPD)United Kingdom
-
Fundació Institut de Recerca de l'Hospital de la...RecruitingBorderline Personality Disorders | BPDSpain
-
Hospital Universitari Vall d'Hebron Research InstituteUnknownBorderline Personality Disorder.Spain
-
Universidad Nacional Autonoma de MexicoCompletedPsychopathic Personality TraitMexico
-
Silvia Elisa Hurtado SantiagoCompletedPersonality Disorder, BorderlineSpain
-
Health Service Executive, IrelandCompletedPersonality Disorder, Borderline